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Summary
Objectives: This study was performed to identify the risk factors for recurrent catheter-related
infections (CRIs) following non-tunneled central venous catheter (CVC) reinsertion after cathe-
ter-related bloodstream infections (CRBSIs).
Methods: A retrospective cohort was constructed from a computer database for patients who
underwent reinsertion of a non-tunneled CVC after a CRBSI during the period January 2004 to
December 2007. Among these patients, recurrent CRI cases were selected through an electronic
chart review, and the risk factors for recurrent CRI were investigated.
Results: Fifty-three patients who had had a reinserted non-tunneled CVC after a CRBSI were
analyzed and 22 patients were considered as having recurrent CRIs (41.5%). Recurrent/persistent
CRBSI after catheter reinsertion was observed in 16 patients, and six patients with systemic
inflammatory response syndrome revealed positive results of an identical organism with the
initial CRBSI in semi-quantitative reinsertion-catheter tip cultures. In multivariate analysis,
fungal CRBSI compared with bacterial infection (adjusted hazard ratio (HR) 7.77, 95% confidence
interval (CI) 1.71—35.36) and CRBSI occurrence during intensive care unit (ICU) care (adjusted HR
5.20, 95% CI 1.41—19.18) were revealed as independent risk factors for recurrent CRIs after
catheter reinsertion on account of CRBSIs.
Conclusions: A substantial proportion of the patients with CRBSIs revealed recurrent CRIs after
catheter reinsertion. Fungal CRBSIs when compared with bacterial infections and CRBSI occur-
rence during ICU care were independent risk factors for recurrent CRIs following catheter
reinsertion after a CRBSI.
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Vascular catheter-related bloodstream infections (CRBSIs)
have become a leading cause of healthcare-associated blood-
stream infections, and are associated with substantial mor-Published by Elsevier Ltd. All rights reserved.
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removal of the catheter is generally recommended for non-
tunneled central venous catheters (CVCs).4,5 However, a
substantial proportion of patients with CRBSIs require rein-
sertion of their CVC for various reasons, such as the admin-
istration of fluid therapy, medications, blood products, and
parenteral nutrition. During catheter exchange for CRBSIs,
guide-wire exchange appears to be associated with a greater
risk of catheter colonization and catheter-related infections
(CRI), however this finding has not been found to be statis-
tically significant.6 In one study, the transfusion of blood
products was found to be associated with recurrent CRBSIs.7
Both the removal of an ‘old’ catheter prior to a de novo
insertion of a new line and antibiotic prophylaxis are also
recommended during catheter exchange.8 However, data
related to the risk factors associated with recurrent CRIs
following catheter reinsertion are scarce. In this study, we
organized a retrospective cohort of patients who had had a
reinserted non-tunneled CVC after a CRBSI, and we investi-
gated the risk factors contributing to their recurrent CRIs.
Materials and methods
Study population and hospital setting
We collected clinical data between January 2004 and Decem-
ber 2007 at a single 2000-bed tertiary hospital. Using the
computer database, we constructed a retrospective cohort of
patients who had revealed CRBSI as defined below. Among the
CRBSI patients, eligible cases were selected through an
electronic chart review for those who had had a reinserted
non-tunneled CVC. The clinical findings and microbiology
data were analyzed for the recurrent CRIs in this population.
Patients with multiple CVCs during the CRBSI were excluded
from the recurrent CRI analysis.
For CVC insertion, a chlorhexidine/silver sulfadiazine sur-
face-treated polyurethane catheter (two-lumen central
venous catheterization set with blue Flextip1 ARROWg+ard-
Blue1 catheter, Teleflex, USA) was used for non-tunneled
CVC insertion. Maximal sterile barrier precautions (gloves,
gown, mask, cap, and large drape) and use of 2% chlorhex-
idine for skin antisepsis during CVC insertion were taken as
standard of care by the institutional infection committee as
suggested in the practice guidelines.9 In cases of recurrent or
persistent CRBSIs, further occult infection foci were evalu-
ated, including infective endocarditis, endophthalmitis, and
infected thrombi.
Microbiologic criteria
CRBSI was defined by positive blood cultures obtained from a
peripheral vein and semi-quantitative catheter tip cultures
yielding more than 15 colonies for the same organism with an
identical antimicrobial susceptibility, without an obvious
source of infection apart from the central line.4,5 Patients
with a single positive blood culture of coagulase-negative
staphylococci (CNS) were excluded from the analysis.
Recurrent CRI was defined by the following criteria: (1)
recurrent positive blood culture of identical organism after
catheter exchange and three negative blood cultures; (2)
persistent positive blood cultures after catheter exchangeand positive semi-quantitative reinsertion-catheter tip cul-
tures (yielding more than 15 colonies) of an identical organ-
ism; (3) positive semi-quantitative reinsertion-catheter tip
cultures (yielding more than 15 colonies) of an identical
organism with systemic inflammatory response syndrome
(SIRS) upon catheter removal, without an obvious source
of infection apart from the central line.
Data collection and study design
Collected data included patient demographics, underlying
comorbidities, types of initial catheter, administration of
total parenteral nutrition/lipid formula/blood products via
the reinsertion catheter, date of the CRBSI, date and time
that the appropriate antibiotics were administered, date and
time of catheter insertion/removal, isolated microorgan-
isms, methods of catheter change (guide-wire vs. de novo
site), and date/type of recurrence. Appropriate antibiotic
administration was defined as parenteral administration of
antibiotics for which the CRBSI-related microorganism
revealed susceptibility, for more than 14 days. We defined
three parameters related with catheter reinsertion to iden-
tify the risk factors contributing to recurrent CRI during a
catheter exchange: (1) catheter removal after CRBSI: time
between the initial CRBSI and the catheter removal; (2)
catheter exchange interval: time between the initial cathe-
ter removal and the reinsertion of a CVC; and (3) pre-reinser-
tion treatment duration: time between the initiation of the
appropriate antibiotics for the CRBSI and the CVC reinsertion.
The primary endpoint was recurrence of the CRI after the
reinsertion of a CVC. Mean comparisons for the continuous
variables were done using independent Student t-tests. Pro-
portion comparisons for the categorical variables were done
using Chi-square tests, and a Fisher’s exact test was used
when the data were sparse. Multivariate logistic regression
analyses with a stepwise model selection procedure were
performed to identify independent risk factors contributing
to recurrent CRIs after CRBSIs and CVC reinsertion. Prede-
fined variables which have been known to be associated with
recurrent CRIs and variables revealing p < 0.1 in our study
were included in the final model. Kaplan—Meier survival
analyses were performed to estimate catheter survival with-
out recurrent CRI according to independent variables identi-
fied in the multivariate logistic regression model.
Significance was set at p < 0.05 using two-sided comparisons,
and all of the analyses were performed using SAS version
9.1.3 (SAS Institute, Inc., Cary, NC, USA).
Results
During the study period, 151 CRBSI cases were identified.
Candida albicans was the most common pathogen (n = 44,
29.1%), followed by Staphylococcus aureus (n = 21, 13.9%)
(Table 1). Most cases were associated with non-tunneled
CVCs (81.5%); venous ports were the next most common
(11.3%). Among 123 non-tunneled CVC CRBSIs, the most
frequent insertion site was the femoral vein (43.9%), fol-
lowed by the subclavian (33.3%) and jugular (22.0%) veins.
The median interval between the initial catheter insertion
and the CRBSI was 17 days (interquartile range 10—25
days).
Table 1 Microbiologic data of the initial catheter-related bloodstream infections and reinsertion non-tunneled central venous
catheters
Initial CRBSI (n = 151) Eligible cases among non-tunneled CVC reinsertion (n = 53)
Recurrent CRI (n = 22) Non-recurrent CRI (n = 31) p-Value
Fungus (n = 85; 56.3%)
Candida albicans 44 (29.1) 7 (31.8) 12 (38.7) 0.606
Candida tropicalis 17 (11.3) 5 (22.7) 2 (6.5) 0.113
Candida parapsilosis 14 (9.3) 4 (18.2) 1 (3.2) 0.147
Candida glabrata 4 (2.6) 0 0
Pichia anomala 4 (2.6) 2 (9.1) 0 0.168
Other 2 (1.3) 1 (4.5) 0 0.415
Bacteria (n = 66; 43.7%)
Staphylococcus aureus 21 (13.9) 2 (9.1) 2 (6.5) 1.000
Coagulase-negative staphylococci 19 (12.6) 0 9 (29.0) 0.007
Enterococcus spp 14 (9.3) 0 2 (6.5) 0.505
Acinetobacter baumannii 3 (2.0) 0 0
Klebsiella pneumoniae 2 (1.3) 0 1 (3.2) 1.000
Other Gram-negative organism 7 (4.6) 1 (4.5) 2 (6.5) 1.000
Data are presented as the number of patients (%) unless otherwise indicated.
Figure 1 Eligible case selection for recurrent catheter-related
infection (CRI) evaluation. Thirty-five cases were excluded
among 88 non-tunneled central venous catheter (CVC) reinser-
tion cases, and 53 eligible cases were selected (BSI, blood stream
infection; CRBSI, catheter-related blood stream infection; RC,
reinsertion catheter; SIRS, systemic inflammatory response syn-
drome).
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a non-tunneled CVC after the initial catheter removal,
excluding patients with multiple CVCs. Among the 88
patients, 35 cases were excluded from the analysis
(Figure 1). Nine patients died without either recurrent CRBSI
documentation or reinsertion catheter tip culture studies.
Sixteen patients met SIRS criteria when the reinsertion
catheters were removed, but no evidence of recurrent CRIs
was observed. Nine patients revealed persistent BSI more
than 48 hours after the reinsertion CVC was removed. These
patients were considered as having an occult infection focus
apart from the CVC. One patient revealed persistent BSI
without CRI evidence.
Among the remaining 53 patients, 22 patients (41.5%)
were considered as having recurrent CRIs after the initial
CRBSI. Recurrent CRBSIs were the most common cause
(n = 12, 54.5%), followed by recurrent CRIs with SIRS
(n = 6, 27.3%) and persistent BSIs with CRIs (n = 4, 18.2%).
C. albicans was the most common pathogen among recurrent
CRIs after a CRBSI, followed by Candida tropicalis (Table 1).
Among the nine CNS CRBSI cases, no recurrent CRIs were
observed after CVC reinsertion and this was statistically
significant ( p = 0.007).
Comparing the recurrent CRI group after CRBSI with the
non-recurrent CRI group (Table 2), the mean age was not
different between the two groups, but the proportion of
males was greater than females (77.3% vs. 45.2%,
p = 0.019). The mean APACHE II score was higher in the
recurrent CRI group (11.8 vs. 9.0, p = 0.017), and more
patients were under intensive care unit (ICU) care when
the initial CRBSI occurred (68.2% vs. 32.3%, p = 0.010). Fungal
CRBSIs resulted in recurrent CRIs after catheter reinsertion
more frequently than bacterial infections (55.9% vs. 15.8%,
p = 0.005). The Charlson index, underlying comorbidities,
and delayed administration of appropriate antibiotics
(>48 hours after CRBSI) were not associated with recurrent
CRIs. Analysis of the mean catheter removal after CRBSI,
catheter exchange interval, and pre-reinsertion treatment
Table 2 Comparison between the recurrent and the non-recurrent catheter-related infection groups
Recurrent CRI
(n = 22; 41.5%)
Non-recurrent
CRI (n = 31; 58.5%)
p-Value
Mean age, years 65.9 60.0 0.167
Male sex 17 (77.3) 14 (45.2) 0.019
Charlson index, mean 3.14 3.06 0.913
APACHE II score, mean 11.8 9.0 0.017
Type of initial catheter
Non-tunneled CVC 18 (81.8) 27 (87.1)
Venous port 3 (13.6) 3 (9.7)
Hemodialysis catheter 1 (4.5) 1 (3.2) 0.505
Site of CVC reinsertion
Subclavian 15 (68.2) 12 (38.7)
Jugular 0 6 (19.4)
Femoral 7 (31.8) 13 (41.9) 0.131
Underlying disease
Malignancy 11 (50) 13 (41.9) 0.561
Diabetes mellitus 7 (31.8) 6 (19.4) 0.299
Renal disease 6 (27.3) 6 (19.4) 0.524
Heart failure 2 (9.1) 3 (9.7) 1.000
Liver cirrhosis 0 2 (6.5) 0.505
Neutropenia 3 (13.6) 1 (3.2) 0.295
Initial CRBSI during ICU management 15 (68.2) 10 (32.3) 0.010
Transfusion 11 (50) 19 (61.3) 0.414
TPN 20 (90.9) 28 (90.3) 1.000
Lipid formula 13 (59.1) 16 (51.6) 0.680
Major surgery 6 (27.3) 7 (22.6) 0.696
Microorganism
Bacteria 3 (13.6) 16 (51.6)
Fungus 19 (86.4) 15 (48.4) 0.005
Catheter removal after CRBSI, mean hours 57.8 55.3 0.833
Catheter exchange interval, mean hours 14.8 23.9 0.589
Pre-reinsertion treatment duration, mean hours 23.4 28.9 0.810
Early initiation of appropriate treatment (<48 hours) 9 (40.9) 14 (45.2) 0.758
Reinsertion catheter survival, mean days 7.8 21.6 <0.001
CRI, catheter-related infection; CVC, central venous catheter; CRBSI, catheter-related blood stream infection; ICU, intensive care unit;
TPN, total parenteral nutrition.
Data are presented as the number of patients (%) unless otherwise indicated.
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groups. All patients received appropriate antibiotic treat-
ment and there was no case of catheter exchange with guide-
wire. The mean catheter survival time was significantly
longer in the non-recurrent group (21.6 vs. 7.8 days,
p < 0.001).
A logistic-regression model was used to identify any inde-
pendent risk factors contributing to recurrent CRIs after a
CRBSI. Variables incorporated into the model were age, sex,
APACHE II score, Charlson index, neutropenia, malignancy,
transfusion,7 ICU care during the initial CRBSI, reinsertion
site of non-tunneled CVC, interval between initial CRBSI and
catheter removal,10 and fungal CRBSIs when compared with
bacterial infections. In the multivariate analysis (binary
logistic, forward-conditional), fungal CRBSIs when comparedwith bacterial infections (adjusted hazard ratio (HR) 7.77,
95% confidence interval (CI) 1.71—35.36) and CRBSI occur-
rence during ICU care (adjusted HR 5.20, 95% CI 1.41—19.18)
were revealed as independent risk factors for recurrent CRIs
after CRBSIs and catheter reinsertion.
In the Kaplan—Meier survival analyses estimating catheter
survival without recurrent CRI, fungal CRBSIs compared with
bacterial infections and CRBSI occurrence during ICU man-
agement adversely affected the recurrent CRIs with statis-
tical significance (log rank test, Figure 2).
Discussion
It is well known that a prolonged catheter indwelling time is
related to an increased risk of CRI. If the indwelling time is
Figure 2 Kaplan—Meier survival analyses regarding the interval between catheter reinsertion and the occurrence of recurrent
catheter-related infections (CRIs) determined by (a) fungal catheter-related blood stream infections (CRBSIs) compared with bacterial
infections and (b) CRBSI occurrence during intensive care unit (ICU) management.
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However, the practice of routine replacement of CVCs in the
absence of any clinical signs of infection, has revealed no
decrease in the infection rates and increased morbidity due
to mechanical complications.9,10 In the cases of CRIs, some
investigators have reported increases in CRBSIs associated
with catheter exchange over the guide-wire.11,12 However,
other studies have not revealed significant increases in
infectious complications with this procedure.13 Apart from
the reinsertion method related to the guide-wire exchange,
data are sparse regarding the risk factors related to recurrent
CRIs after catheter exchange or reinsertion. Some authors
recommend that the ‘old’ line should be removed prior to the
insertion of the ‘new’ line, if possible.8 Recently, risk factors
and outcomes associated with recurrent CRBSIs have been
investigated.7 In this study, the authors reported 34% of
recurrent CRBSIs after catheter reinsertion, and suggested
transfusion of blood products as an independent risk factor
for recurrent CRBSIs.
Our study included not only recurrent CRBSIs, but also
recurrent CRI cases. For the specificity issues of recurrent
CRIs, patients without SIRS or documented exit site infec-
tions were not regarded as having recurrent CRIs even if
the semi-quantitative reinsertion-catheter tip culture
yielded more than 15 colonies of the identical organism
isolated from the initial CRBSI. For recurrent/persistent
CRBSIs, nine cases revealed persistent bacteremia more
than 48 hours after the reinsertion catheter was removed.
We excluded these cases from the analysis because we
could not rule out occult infection foci unrelated to the
reinsertion of the CVC.
Regarding risk factors for recurrent CRIs after CRBSIs,
fungal CRBSIs compared with bacterial infections and CRBSI
occurrence during ICU management were independently
associated with recurrent CRIs in the multivariate analysis.
It has been accepted as the standard of care to remove the
CVC in patients with candidemia to improve clinical out-
comes,10,14,15 although some authors are not in line with
this strategy.16,17 In this study, we found that the fungalCRBSIs were related with recurrent CRIs even if the
infected catheters were removed and appropriate antibio-
tic administration was implemented. In a previous study,14
CVC retention more than 72 hours after candidemia was
related with a decreased response to antifungal therapy, as
well as increased mortality and morbidity when candide-
mia was related with the CRI. However, among the 31
CRBSI cases of Candida spp in our study population, the
interval between CRBSI and catheter removal was not
different between the recurrent group and the non-recur-
rent group (70.0 h vs. 64.3 h, p = 0.779). In contrast to
fungal CRBSIs, no recurrent CRIs were observed among the
nine CNS-associated CRBSI cases and this was statistically
significant. We suppose that this is related to the lesser
virulence of this organism.
We attempted to identify the modifiable risk factors that
influence recurrent CRIs after a CRBSI, such as the time lapse
before catheter removal after CRBSI, the catheter exchange
interval, and the time lapse before catheter reinsertion after
appropriate antibiotic administration. However, we failed to
find a link between these variables and recurrent CRIs. The
mean catheter exchange interval was slightly longer in the
non-recurrent group, but this was not statistically significant.
This is one of the issues emphasized for further investigation
in the previous Infectious Diseases Society of America guide-
lines,5 but there is little correlated data. As previously
reported,7 a substantial proportion of patients underwent
the reinsertion of a new catheter immediately after or even
before the initial catheter was removed during their manage-
ment of the CRBSI in our study, and this might have resulted in
a limited significance of the catheter exchange interval for
recurrent CRIs.
Initial CRBSI occurrence during ICU management was
revealed as an independent risk factor for recurrent CRIs
in our study. We suppose that host immunity, which was not
appropriately measured in our study model, or the resistance
of the microorganism involved in the initial CRBSI among ICU
patients, might influence the recurrence of CRIs. However,
microbiologic verification regarding ICU preponderance for
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Candida spp were susceptible to fluconazole and the CNS
isolates did not recur irrespective of their methicillin sensi-
tivity (data not shown).
In our study, the proportion of fungal infections was
relatively high among the initial CRBSIs (85/151, 56.3%).
We suppose this is related to our inclusion criteria for
CRBSIs, which required a positive semi-quantitative cathe-
ter tip culture. It has become the standard of care to
remove the CVC immediately when candidemia occurs. So
this policy might have resulted in a higher frequency of
fungal CRBSIs in our study group because catheter-sparing
management is more frequently tried in bacterial CRBSI
cases, such as CNS.
The rate of recurrent CRIs was relatively high (41.5%) in
our study. Among the 88 patients who had a reinserted CVC
after a CRBSI, we excluded 16 patients from the analysis
because they met the SIRS criteria when the reinsertion
catheter was removed, but did not reveal a significant
catheter tip colonization. Although a substantial propor-
tion of these patients may not have had recurrent CRIs,
these cases were excluded from the analysis because we
could not rule out the possibility of recurrent CRIs below
the sensitivity of the semi-quantitative tip culture methods
such as exit site infection. This might have resulted in an
increased proportion of recurrent CRI cases. If we limit the
analysis to recurrent CRBSIs according to a previous
report,7 the recurrence rate would be 24.5% (12/49,
excluding four persistent bacteremia cases), lower than
that of the report (34%).
In conclusion, a substantial proportion of patients with
CRBSIs revealed a recurrent CRI after catheter reinsertion
(41.5%). Fungal CRBSIs compared with bacterial infections
and CRBSI occurrence during ICU care were independent risk
factors for recurrentCRIsafterCRBSIsandcatheterreinsertion.
Our study has several limitations. First, the study number
was relatively small and the proportion of fungal CRBSIs was
relatively high. However, we confirmed that the microbiolo-
gic features, which determine management strategy for the
catheter in CRBSIs, also influence the prognosis of a rein-
serted catheter even after the initial catheter is removed.
Second, CRBSIs related to the exit site or tunnel infections
were not included in our study. This might have influenced
the epidemiologic features of CRBSIs. However, our micro-
biologic criteria using mainly semi-quantitative catheter tip
cultures might be a relatively objective measurement, and
this might contribute to reducing any biases in selecting the
eligible cases.
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